# High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)

> **NCT06092424** · NA · UNKNOWN · sponsor: **University of Zurich** · enrollment: 36 (estimated)

## Conditions studied

- Pulmonary Vascular Disease
- Pulmonary Arterial Hypertension
- Chronic Thromboembolic Pulmonary Hypertension

## Interventions

- **BEHAVIORAL:** Relocation from HA to LA

## Key facts

- **NCT ID:** NCT06092424
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-23
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06092424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06092424, "High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06092424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*